Abstract
Purpose
To identify the leading treatment strategies for infertile women with PCOS on an international scale.
Methods
A retrospective evaluation using the results of a web-based survey, (IVF-Worldwide (www.IVF-worldwide.com), posted from 1 to 30 September 2010 was performed. Binomial confidence intervals for proportions were calculated by the modified Wald method with significance defined as P < 0.05 using a DataStar software package (DataStar, Waltham, MA, USA). Incomplete surveys were excluded from the analysis.
Results
The results from 262 centers in 68 nations were obtained. Clomiphene citrate was the clear first choice, 68 %, for PCOS treatment in the respondent group. Eighty-eight percent of respondents utilized ultrasound follicular monitoring when conducting ovulation induction with oral medications. A significant (p < 0.05) proportion of respondents (66 %) did use some BMI cutoff beyond which IVF treatment was not offered. The preferred IVF protocols for PCOS patients were gonadotropin releasing hormone (GnRH) antagonist, 46 %, and GnRH agonist, 51 %. There was heterogeneity of responses observed regarding the management of a patient at very high risk of OHSS.
Conclusions
While some advances, such as the use of GnRH antagonist regimen in IVF cycles, were relatively underutilized, the survey gives an unfiltered snapshot at the practice patterns of a large number of clinics. Results from this survey may be used by researchers and professional organizations to improve the clinical care of PCOS women suffering with infertility.
Similar content being viewed by others
References
Al-Inany HG, Youssef MA, Aboulghar M, Broekmans F, Sterrenburg M, Smit J, et al. Gonadotropin-releasing hormone antagonsists for assisted reproductive technology. Cochrane Database Syst Rev. 2011;11(5), CD001750. doi:10.1002/14651858.CD001750.pub3.
Casper RF, Mitwally MF. Review: Aromatase inhibitors for ovulation induction. J Clin Endocrinol Metab. 2006;91(3):760–71.
Casper RF, Mitwally MF. A historical perspective of aromatase inhibitors for ovulation induction. Fertil Steril. 2012;98(6):1352–5.
Costello M, Misso M, Wong J, et al. The treatment of infertility in Polycystic ovarian syndrome: a brief update. Aus N Z J Obstet Gynaecol. 2012;52(4):400–3. doi:10.1111/j.1479-828X.2012.01448.
Giannopoulos T, Sherriff E, Croucher C. Follicle tracking of women receiving clomiphene citrate for ovulation induction. J Obstet Gynaecol. 2005;25(2):169–71.
Homberg R. Management of infertility and prevention of ovarian hyperstimulation in women with polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol. 2004;18:773–88.
Lee VC, Ledger W. Aromatase inhibitors for ovulation induction and ovarian stimulation. Clin Endocrinol (Oxf). 2011;74(5):537–46. doi:10.1111/j.1365-2265.2011.04006.
Magann EF, Doherty DA, Sandlin AT, Chauhan SP, Morrison JC. The effects of an increasing gradient of maternal obesity on pregnancy outcomes. Aus N Z J Obstet Gynaecol. 2013. doi:10.1111/ajo.12047.
Maheshwari A, Stofberg L, Bhattacharya S. Effect of overweight and obesity on assisted reproductive technology—a systematic review. Hum Reprod Update. 2007;13(5):433–44.
Nahid L, Sirous K. Comparison of the effects of letrozole and clomiphine citrate for ovulation induction in infertile women with polycystic ovary syndrome. Minerva Ginecol. 2012;64(3):253–8.
Pettigrew R, Hamilton-Fairley D. Obesity and female reproductive function. Br Med Bull. 1997;53(2):341–58.
Pinborg A, Gaarsley C, Hougaard CO, Nyboe Andersen A, Andersen PK, Boivin J, et al. Influence of female bodyweight on IVF outcome: a longitudinal multicentre cohort study of 487 infertile couples. Reprod Biomed Online. 2011;23(4):490–9. doi:10.1016/j.rbmo.2011.06.010.
Shalom-Paz E, Marzal A, Wiser A, Almong B, Reinblatt S, Tulandi T, et al. Effects of different body mass indices on in vitro maturation in women with polycystic ovaries. Fertil Steril. 2011;96(2):336–9.
Teede H, Deeks A, Moran L. Polycystic ovary syndrome: a complex condition with psychological, reproductive, and metabolic manifestations that impacts on health across the lifespan. BMC Med. 2010;8:41–50.
Tulandi T, Martin J, Al-Fadhli R, Kabli N, Forman R, Hitkari J, et al. Congenital malformations among 911 newborns conceived after infertility treatment with letrozole or clomiphene citrate. Fertil Steril. 2006 Jun;85(6):1761–5.
Wilkes S, Murdoch A. Ovulation induction with clomiphene: a primary care perspective. J Fam Plann Reprod Health Care. 2012;38(1):48–52. doi:10.1136/jfprhc-2011-0103.
Xiao J, Chen S, Zhang C, Chang S. Effectiveness of GnRH antagonist in the treatment of patients with polycystic ovary syndrome undergoing IVF: a systematic review and meta-analysis. Gynecol Endocrinol. 2013;29(3):187–91. doi:10.3109/09513590.2012.736561.
Zander-Fox DL, Henshaw R, Hamilton H, Lane M. Does obesity really matter? The impact of BMI on embryo quality and pregnancy outcomes after IVF in women aged ≤38 years. Aus N Z J Obstet Gynaecol. 2012;52(3):270–6.
Author information
Authors and Affiliations
Corresponding author
Additional information
Capsule
This study describes the treatment patterns for PCOS via a survey of 262 centers in 68 nations.
Rights and permissions
About this article
Cite this article
Brezina, P.R., Mensah, V., Balen, A. et al. Fertility management in the PCOS population: results of a web-based survey at IVF-worldwide.com. J Assist Reprod Genet 30, 1169–1174 (2013). https://doi.org/10.1007/s10815-013-0069-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10815-013-0069-z